Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 18, 1999, Pages 2747-2752

  Lin, Nan Horng ^a   Abreo, Melwyn A ^a   Gunn, David E ^a   Lebold, Suzanne A ^a   Lee, Edmund L ^a   Wasicak, James T ^a   Hettinger, Ann Marie ^a   Daanen, Jerome F ^a   Garvey, David S ^a   Campbell, Jeffrey E ^a   Sullivan, James P ^a   Williams, Michael ^a   Arneric, Stephen P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINE DERIVATIVE; DRUG ANALOG; ETHER DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CHOLINERGIC AGONISTS; ETHERS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0033588905     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00462-X     Document Type: Article

References (18)

1. 1. Nordberg, A. J. Reprod. Fert. Suppl. 1993, 46, 145-154.
2. 2. Sargent, P. B. Annual Review of Neuroscience. 1993, 16, 403-443.
3. 3. Arneric, S. P.; Sullivan, J. P.; Briggs, C. A.; Donnelly-Roberts, D.; Anderson, D. J.; Raszkiewicz, J. L.; Hughes, M. L.; Cadman, E. D.; Adams, P.; Garvey, D. S.; Wasicak, J. T.; Williams, M. J. Pharmacol, Exp. Therap. 1994, 270, 310-318.
4. 4. Meyer, E. M.; de Fiebre, C. M.; Hunter, B. E.; Simpkins, C. E.; Frauworth, N.; de Fiebre, N. E. C. Drug Development Research. 1994, 31, 127-134.
5. 5. Garvey, D. S.; Wasicak, J. T.; Decker, M. W.; Brioni, J. D.; Buckley, M. J.; Sullivan, J. P.; Carrera, G. M.; Holladay, M. W.; Arneric, S. P.; Williams, M. J. Med. Chem. 1994, 37, 1055-1059.
6. 6. Garvey, D. S.; Wasicak, J. T.; Elliott, R. L.; Lebold, S. A.; Hettinger, A.-M.; Carrera, G. M.; Lin, N.-H.; He, Y.; Holladay, M. W.; Anderson, D. J.; Cadman, E. D.; Raszkiewicz, J. L.; Sullivan, J. P.; Arneric, S. P. J. Med. Chem. 1994, 37, 4455-4463.
7. 7. Lin, N.-H.; He, Y.; Anderson, D. J.; Wasicak, J. T.; Kasson, R.; Sweeny, D.; Sullivan, J. P.. Bioorg. Med. Chem. Lett 1994, 4, 2389-2394.
8. 8. Lin, N.-H.; He, Y.; Arneric, S. P.; Sullivan, J. P. Bioorg. Med. Chem. Lett. 1995, 5, 1141-1146.
9. 9. Arneric, S. P.; Anderson, D. J.; Bannon, A. W.; Briggs, C. A.; Buccafusco, J. J.; Brioni, J. D.; Decker, M. W.; Donnelly-Roberts, D.; Gopalakrishnan, M.; Holladay, M. W.; Kyncl, J.; Marsh, K. C.; Pauly, J.; Radek, R. J.; Rodrigues, D.; Sullivan, J. P. CNS Drug Rev. 1995, 1, 1-26.
10. 10. Decker, M. W.; Brioni, J. D.; Sullivan, J. P.; Buckley, M. J.; Radek, R. J.; Raszkiewicz, J. L.; Kang, C. H.; Kim, D. J. B.; Giardina, W. J.; Wasicak, J. T.; Garvey, D. S.; Williams, M.; Arneric, S. P. J. Pharmacol. Exp. Therap. 1994, 270, 319-328.
11. 11. Brioni, J. D.; Kim, D. J. B.; Brodie, M. S.; Decker, M. W.; Arneric, S. P. Psychopharmacology. 1995, 119, 368-375.
12. 12. Abreo, M. A.; Lin, N.-H.; Garvey, D. S.; Gunn, D. E.; Hettinger, A.-M.; Wasicak, J. T.; Pavlik, P. A.; Martin, Y. C.; Donnelly-Roberts, D. L.; Anderson, D. J.; Sullivan, J. P.; Williams, M.; Arneric, S. P.; Holladay, M. W. J. Med. Chem. 1996, 39, 817-825.
13. 13. Wada, E.; Wada, K.; Boulter, J.; Deneris, E.; Heinemann, S.; Patrick, J.; Swanson, L. W. J. Comp. Neurol. 1989 ,284, 314-335.
14. 14. Flores, C. M.; Rogers, S. W.; Pabreza, L. A.; Wolfe, B. B.; Kellar, K. J. Mol Pharmacol. 1991, 41, 31-37.
15. 15. Seguela, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J. A.; Patrick, J. W. J. Neurosci. 1993, 13, 596-604.
16. 16. Unpublished result.
17. 17. Beers, W. H.; Reich, E. Nature. 1970, 225, 917-922.
18. 18. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. J. Med. Chem. 1986, 29, 899-906.